Found 6 matching trials
Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma
PHASE3The primary objective of this study is to evaluate the efficacy of tisleliz...
Location
Beijing Cancer Hospital
A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma
PHASE3This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)
PHASE3The primary objective of this study is to evaluate the efficacy of GLS-010 ...
Location
Multiple Locations
Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLs
PHASE1This is a two stage, Phase I/II clinical trial for patients with relapsed o...
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCL
PHASE2The purpose of this multi-center,single arm,phase Ⅱ clinical trail is to de...
Location
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
PHASE2This randomized phase II trial studies the side effects and how well giving...
Location
Cancer and Leukemia Group B